Treating traumatic bleeding in a combat setting: possible role of recombinant activated factor VII.
about
Intravenously administered nanoparticles increase survival following blast trauma.Mechanistic implications for the use and monitoring of recombinant activated factor VII in trauma.Safety of rFVIIa in hemodynamically unstable polytrauma patients with traumatic brain injury: post hoc analysis of 30 patients from a prospective, randomized, placebo-controlled, double-blind clinical trialIntravenous hemostats: challenges in translation to patientsIntravenous hemostatic nanoparticles increase survival following blunt trauma injury.Tuning ligand density on intravenous hemostatic nanoparticles dramatically increases survival following blunt trauma.
P2860
Treating traumatic bleeding in a combat setting: possible role of recombinant activated factor VII.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Treating traumatic bleeding in ...... ombinant activated factor VII.
@ast
Treating traumatic bleeding in ...... ombinant activated factor VII.
@en
type
label
Treating traumatic bleeding in ...... ombinant activated factor VII.
@ast
Treating traumatic bleeding in ...... ombinant activated factor VII.
@en
prefLabel
Treating traumatic bleeding in ...... ombinant activated factor VII.
@ast
Treating traumatic bleeding in ...... ombinant activated factor VII.
@en
P2093
P1433
P1476
Treating traumatic bleeding in ...... ombinant activated factor VII.
@en
P2093
Amir Blumenfeld
Bar-Lavie Yaron
Giora Martonovits
Menashe Zaarur
Uri Martinowitz
P304
P433
P577
2004-12-01T00:00:00Z